As shown in Figure 3a,b, the NF-κB levels in nuclei were augmented by the AOM/DSS treatment and were substantially decreased in the 2.5 and 5 mg/kg tussilagone-administered mice. This evidence concerns the gene NFKB1 and infectious otitis media.